This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which is being held from Jan. 25 to Jan. 30.
For more information and registration details, visit SMFM.org.
According to information presented on Thursday, Jan. 28, at SMFM’s 41st Annual Pregnancy Meeting, pregnant women who become severely or critically ill because of COVID-19 are at a greater risk of dying and experiencing serious pregnancy complications. These women were compared to those who have had COVID-19 but were asymptomatic.
Pregnant women with mild or moderate illness were not at higher risk of pregnancy complications than those without symptoms. The study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, according to SMFM.
The study examined medical records of 1,219 pregnant women from 33 hospitals in 14 states from March 1, 2020 to July 31, 2020. All patients tested positive for COVID-19; 47 percent were asymptomatic, 27 percent were mild, 14 percent were moderate, 8 percent were severe, and 4 percent were critical.
“Our research shows that serious pregnancy complications appear to occur in women who have severe or critical cases of COVID and not those who have mild or moderate cases,” said Torri D. Metz, MD, MS, who is a maternal-fetal medicine subspecialist and associate professor at the University of Utah Health. Metz was the study’s lead author.
According to SMFM, findings also showed that pregnant women who become severely or critically ill due to COVID-19 were older, had a higher body mass index, and were more likely to have underlying medical conditions, such as asthma/chronic obstructive pulmonary disease (COPD), diabetes, and high blood pressure. These women were more likely to die or have serious complications, such as cesarean delivery; heavy bleeding after giving birth, known as postpartum hemorrhage; high blood pressure during pregnancy; and preterm birth. High blood pressure and preterm birth also have the potential to cause long-term health problems in women or their infants.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More